Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04100018
Title A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer (CheckMate 7DX)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb

prostate adenocarcinoma


Docetaxel + Nivolumab + Prednisone

Docetaxel + Prednisone

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

No variant requirements are available.